文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

术前 3-T 多参数 MRI 和 Ga-PSMA PET/CT 扫描对前列腺癌根治性前列腺切除术和盆腔淋巴结清扫术病理结果的预测价值的组织学比较。

Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.

机构信息

The Wesley Hospital, Brisbane, Queensland, Australia.

Wesley Medical Research, Brisbane, Queensland, Australia.

出版信息

BJU Int. 2021 Jan;127(1):71-79. doi: 10.1111/bju.15134. Epub 2020 Sep 7.


DOI:10.1111/bju.15134
PMID:32524748
Abstract

OBJECTIVE: To evaluate the ability of preoperative multiparametric magnetic resonance imaging (mpMRI) and a gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography ( Ga-PSMA PET/CT) scan to predict pathological outcomes and also identify a group of men with a <5% risk of histological pelvic lymph node metastasis (LNM) at pelvic lymph node dissection (PLND) performed during a robot-assisted laparoscopic radical prostatectomy (RALP) for prostate cancer. We then aimed to compare these results to known risk calculators for LNM, including the Cancer of the Prostate Risk Assessment (CAPRA) score, Memorial Sloan Kettering Cancer Centre (MSKCC) and Briganti nomograms. PATIENTS AND METHODS: Between July 2014 and September 2019 only men who had both a preoperative mpMRI and staging Ga-PSMA PET/CT at our institution followed by a RALP with PLND referred to a single specialist uropathology laboratory were considered for inclusion. The data were collected retrospectively prior to February 2019 and in a prospective manner thereafter. A model was built to allocate probabilities of the men with a negative Ga-PSMA PET/CT scan having a <5% risk of histologically LNM at RALP based on the preoperative radiological staging. RESULTS: A total of 233 consecutive men met the inclusion criteria of which 58 men (24.9%) had a LNM identified on PLND histology. The median (range) International Society of Urological Pathology (ISUP) Grade was 5 (1-5) and the median (range) prostate-specific antigen level was 7.4 (1.5-72) ng/mL. The median (range) number of resected lymph nodes was 16 (1-53) and the median (range) number of positive nodes identified on histology was 2 (1-22). Seminal vesicle invasion on mpMRI was more common in node-positive men than in the absence of LNM (31% vs 12%). The maximum standardised uptake value of the primary tumour on Ga-PSMA PET/CT was higher in men with LNM (median 9.2 vs 7.2, P = 0.02). Suspected LNM were identified in 42/233 (18.0%) men with Ga-PSMA PET/CT compared with 22/233 (9.4%) men with mpMRI (P = 0.023). The positive and negative predictive value for Ga-PSMA PET/CT was 66.7% and 84.3% respectively, compared to 59.1% and 78.7% for mpMRI. A predictive model showed only two men (4.2%) with a negative preoperative Ga-PSMA PET/CT would be positive for a histological LNM if they are ISUP Grade < 5 and Prostate Imaging-Reporting and Data System (PI-RADS) <5; or ISUP Grade 5 with PI-RADS < 4. An inspection of three additional variables: CAPRA score, MSKCC and Briganti nomograms did not improve the predictive probability for this group. However, of the 61 men with ISUP Grade 4-5 malignancy and also a PI-RADS 5 mpMRI, 20 (32.8%) men had a microscopic LNM despite a negative preoperative Ga-PSMA PET/CT. CONCLUSION: Preoperative Ga-PSMA/PET CT was more sensitive in identifying histological pelvic LNM than 3-T mpMRI. Men with a negative Ga-PSMA PET/CT have a lower risk of LNM than predicted with CAPRA scores or MSKCC and Briganti nomograms. We identified that the combination of a negative preoperative Ga-PSMA PET/CT, ISUP biopsy Grade <5 and PI-RADS <5 prostate mpMRI, or an ISUP Grade 5 with PI-RADS <4 on mpMRI was associated with a <5% risk of a LNM. The addition of CAPRA scores, MSKCC and Briganti nomograms did not improve the predictive probability within this model. Conversely, men with ISUP Grade 4-5 malignancy associated with a PI-RADS 5 prostate mpMRI had a >30% risk of microscopic LNM despite a negative preoperative Ga-PSMA PET/CT and this high-risk group would appear suitable for an extended PLND at the time of a radical prostatectomy.

摘要

目的:评估术前多参数磁共振成像(mpMRI)和镓-68 前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(Ga-PSMA PET/CT)在预测病理结果方面的能力,并确定一组在机器人辅助腹腔镜前列腺根治性切除术(RALP)中进行盆腔淋巴结清扫术(PLND)时发生组织学盆腔淋巴结转移(LNM)风险<5%的男性。然后,我们旨在将这些结果与已知的 LNM 风险计算器进行比较,包括前列腺癌风险评估(CAPRA)评分、纪念斯隆凯特琳癌症中心(MSKCC)和布里甘蒂诺列线图。

患者和方法:2014 年 7 月至 2019 年 9 月期间,仅对在我院进行术前 mpMRI 和分期 Ga-PSMA PET/CT 检查,随后在单一专科泌尿病理实验室进行 RALP 并进行 PLND 的男性进行了回顾性和前瞻性研究。在 2019 年 2 月之前收集数据,此后以前瞻性方式收集数据。根据术前放射学分期,建立了一个模型,根据 Ga-PSMA PET/CT 扫描结果为阴性的男性,分配其在 RALP 中发生组织学 LNM 的可能性<5%的概率。

结果:共有 233 例连续男性符合纳入标准,其中 58 例(24.9%)在 PLND 组织学上发现 LNM。国际泌尿病理学会(ISUP)分级中位数(范围)为 5(1-5),前列腺特异性抗原水平中位数(范围)为 7.4(1.5-72)ng/ml。切除的淋巴结中位数(范围)为 16(1-53),组织学上阳性淋巴结的中位数(范围)为 2(1-22)。mpMRI 上精囊侵犯在淋巴结阳性男性中比在无 LNM 的男性中更常见(31%比 12%)。Ga-PSMA PET/CT 上原发肿瘤的最大标准化摄取值在有 LNM 的男性中较高(中位数 9.2 比 7.2,P=0.02)。与 mpMRI 相比,Ga-PSMA PET/CT 发现 42/233(18.0%)男性疑似有 LNM,而 mpMRI 发现 22/233(9.4%)男性疑似有 LNM(P=0.023)。Ga-PSMA PET/CT 的阳性和阴性预测值分别为 66.7%和 84.3%,而 mpMRI 分别为 59.1%和 78.7%。预测模型显示,如果术前 Ga-PSMA PET/CT 为阴性且 ISUP 分级<5 和前列腺成像报告和数据系统(PI-RADS)<5;或 ISUP 分级 5 且 PI-RADS<4,则仅 2 名男性(4.2%)的组织学 LNM 为阳性。检查另外三个变量:CAPRA 评分、MSKCC 和布里甘蒂诺列线图并没有提高这一组的预测概率。然而,在 61 名 ISUP 分级 4-5 恶性肿瘤且 mpMRI 分级 PI-RADS 5 的男性中,尽管术前 Ga-PSMA PET/CT 为阴性,但仍有 20 名(32.8%)男性有显微镜下 LNM。

结论:术前 Ga-PSMA/PET CT 在识别组织学盆腔 LNM 方面比 3-T mpMRI 更敏感。与 CAPRA 评分或 MSKCC 和 Briganti 列线图相比,术前 Ga-PSMA PET/CT 阴性的男性发生 LNM 的风险较低。我们发现,术前 Ga-PSMA PET/CT 阴性,ISUP 活检分级<5 和 PI-RADS<5 前列腺 mpMRI,或 ISUP 分级 5 且 PI-RADS<4 的前列腺 mpMRI 与 LNM 风险<5%相关。在该模型中,添加 CAPRA 评分、MSKCC 和 Briganti 列线图并没有提高预测概率。相反,在 ISUP 分级 4-5 恶性肿瘤相关的 PI-RADS 5 前列腺 mpMRI 中,尽管术前 Ga-PSMA PET/CT 为阴性,但仍有>30%的男性发生显微镜下 LNM,这一高危组似乎适合在根治性前列腺切除术时进行扩展的 PLND。

相似文献

[1]
Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.

BJU Int. 2021-1

[2]
Comparison of Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer.

J Transl Med. 2017-11-7

[3]
Diagnostic accuracy of Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of Ga-PSMA PET to mpMRI.

BJU Int. 2019-11

[4]
Outcomes of Primary Lymph Node Staging of Intermediate and High Risk Prostate Cancer with Ga-PSMA Positron Emission Tomography/Computerized Tomography Compared to Histological Correlation of Pelvic Lymph Node Pathology.

J Urol. 2019-4

[5]
Risk of metastatic disease on gallium-prostate-specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer.

BJU Int. 2019-7-2

[6]
Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer.

J Nucl Med. 2021-2

[7]
One-Stop-Shop Whole-Body Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer.

J Nucl Med. 2018-5-24

[8]
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters.

Eur Urol Oncol. 2024-4

[9]
Findings in 1,123 Men with Preoperative Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography and Multiparametric Magnetic Resonance Imaging Compared to Totally Embedded Radical Prostatectomy Histopathology: Implications for the Diagnosis and Management of Prostate Cancer.

J Urol. 2022-3

[10]
Rational use of Ga-68 PSMA PET-CT according to nomograms and risk groups for the detection of lymph node metastasis in prostate cancer.

Urol Oncol. 2024-2

引用本文的文献

[1]
A prospective, multi-centre trial of PSMA-PET compared to FDG-PET for staging of newly diagnosed high risk prostate cancer.

EJNMMI Res. 2025-7-24

[2]
Application of radiomics-based prediction model to predict preoperative lymph node metastasis in prostate cancer: a systematic review and meta-analysis.

Front Oncol. 2025-6-20

[3]
Comparison of mpMRI and Ga-PSMA-PET/CT in the Assessment of the Primary Tumors in Predominant Low-/Intermediate-Risk Prostate Cancer.

Diagnostics (Basel). 2025-5-28

[4]
Head-to-head comparison of GA-68 PSMA PET/CT and multiparametric MRI findings with postoperative results in preoperative locoregional staging and localization of prostate cancer.

Prostate. 2025-1

[5]
Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics.

BJU Int. 2024-12

[6]
Ga-PSMA-11 PET and mpMRI in the diagnosis of initial lymph node staging of prostate cancer: a head-to-head comparative meta-analysis.

Front Med (Lausanne). 2024-6-20

[7]
The value of Ga-PSMA PET/CT in the diagnosis of intracapsular prostate cancer with a poor prognosis.

Discov Oncol. 2024-7-2

[8]
Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?

Prostate Cancer Prostatic Dis. 2024-3-22

[9]
Advances in radiology and pathology of prostate cancer: a review for the pathologist.

Pathologica. 2024-2

[10]
Head-to-head comparison of prostate-specific membrane antigen PET and multiparametric MRI in the diagnosis of pretreatment patients with prostate cancer: a meta-analysis.

Eur Radiol. 2024-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索